Alteplase and tenecteplase: applications in the peripheral circulation (Q34618547)

3 August 2017

1 reference

title

Alteplase and tenecteplase: applications in the peripheral circulation (English)

1 reference

3 August 2017

C P Semba

1

1 reference

3 August 2017

K Sugimoto

series ordinal

2

1 reference

3 August 2017

M K Razavi

series ordinal

3

1 reference

3 August 2017

Society of Cardiovascular and Interventional Radiology (SCVIR)

series ordinal

4

1 reference

3 August 2017

publication date

1 June 2001

1 reference

Techniques in vascular and interventional radiology

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

99-106

1 reference

Surgery versus thrombolytic therapy in the management of peripheral arterial occlusions

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Alteplase as an alternative to urokinase. Advisory Panel on Catheter-Directed Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

On the Kinetics of the Reaction between Human Antiplasmin and Plasmin

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. The Advisory Panel

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Low doses of recombinant human tissue-type plasminogen activator for local thrombolysis in peripheral arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Local thrombolytic therapy of acute peripheral arterial ischaemia with tissue plasminogen activator: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen activator--report of a pilot trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Vascular surgical society of great britain and ireland: avoiding the complications of thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Results of a Prospective Randomized Trial Evaluating Surgery Versus Thrombolysis for Ischemia of the Lower Extremity The STILE Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

A simplified procedure for intra-arterial thrombolysis with tissue-type plasminogen activator in peripheral arterial occlusive disease: primary and long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Bioactivity of cryopreserved alteplase solutions

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Recombinant tissue plasminogen activator (alteplase) for restoration of flow in occluded central venous access devices: a double-blind placebo-controlled trial--the Cardiovascular Thrombolytic to Open Occluded Lines (COOL) efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Third-generation thrombolytic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1089-2516%2801%2990003-4

7 January 2021

10.1016/S1089-2516(01)90003-4

Identifiers

DOI

1 reference

3 August 2017

1 reference